Multiple Sclerosis, Primary Progressive

Also known as: Primary Progressive Multiple Sclerosis / Primary Progressive MS / Primary-progressive Multiple Sclerosis / Primary Multiple Sclerosis, Progressive

DrugDrug NameDrug Description
DB11988OcrelizumabA CD20 specific monoclonal antibody used to treat relapsing remitting multiple sclerosis.
DrugDrug NameTargetType
DB11988OcrelizumabB-lymphocyte antigen CD20target
DrugDrug NamePhaseStatusCount
DB00759Tetracycline0Temporarily Not Available1
DB01076Atorvastatin1Completed1
DB08868Fingolimod1Completed1
DB05259Glatiramer1Completed1
DB00279Liothyronine1Completed1
DB00166Lipoic acid1Completed1
DB00073Rituximab1Completed1
DB00759Tetracycline1Completed1
DB05767Andrographolide1 / 2Recruiting1
DB09081Idebenone1 / 2Active Not Recruiting1
DB09081Idebenone1 / 2Completed1
DB01285Corticotropin2Active Not Recruiting1
DB08908Dimethyl fumarate2Active Not Recruiting1
DB04573Estriol2Recruiting1
DB01611Hydroxychloroquine2Active Not Recruiting1
DB05266Ibudilast2Completed1
DB06685Laquinimod2Completed1
DB00108Natalizumab2Completed1
DB00717Norethisterone2Recruiting1
DB00624Testosterone2Withdrawn1
DB05259Glatiramer2 / 3Completed1
DB00073Rituximab2 / 3Completed1
DB06637Dalfampridine3Completed1
DB08868Fingolimod3Completed2
DB11526Masitinib3Completed1
DB11988Ocrelizumab3Active Not Recruiting2
DB11988Ocrelizumab3Recruiting2
DB06637Dalfampridine4Completed1
DB09150Fludeoxyglucose (18F)Not AvailableRecruiting1
DB11988OcrelizumabNot AvailableRecruiting1